Found: 15
Select item for more details and to access through your institution.
Don't Blame Drug Prices on "Big Pharma" Lawmakers want lower list prices, but insurers are at fault for mismanaging plans.
- Published in:
- Oncology Practice Management, 2019, v. 9, n. 5, p. 38
- By:
- Publication type:
- Article
FDA Approves Keytruda plus Inlyta as First-Line Treatment for Advanced RCC.
- Published in:
- Oncology Practice Management, 2019, v. 9, n. 5, p. 37
- Publication type:
- Article
Balversa Approved for Locally Advanced or Metastatic Urothelial Carcinoma with Certain FGFR Genetic Alterations.
- Published in:
- Oncology Practice Management, 2019, v. 9, n. 5, p. 36
- Publication type:
- Article
Personalizing Immunotherapy in NSCLC Using PD-L1 and Tumor Mutation Burden as Biomarkers.
- Published in:
- Oncology Practice Management, 2019, v. 9, n. 5, p. 34
- By:
- Publication type:
- Article
Adding PARP Inhibitor to Immune Checkpoint Blockade Improves Responses in Ovarian Cancer with BRCA Mutations.
- Published in:
- Oncology Practice Management, 2019, v. 9, n. 5, p. 32
- By:
- Publication type:
- Article
Genomic Markers of Response Improve Patient Selection for Immune Checkpoint Inhibitor Therapy.
- Published in:
- Oncology Practice Management, 2019, v. 9, n. 5, p. 29
- By:
- Publication type:
- Article
CAR T-Cell Therapy Associated with Unique, Acute Adverse Events Requiring Vigilant Monitoring.
- Published in:
- Oncology Practice Management, 2019, v. 9, n. 5, p. 26
- By:
- Publication type:
- Article
Updated NCCN Treatment Guideline for CML Establishes Criteria for Stopping TKI Therapy.
- Published in:
- Oncology Practice Management, 2019, v. 9, n. 5, p. 1
- By:
- Publication type:
- Article
First-Line Pembrolizumab plus Axitinib Combination Boosts Survival in Metastatic Renal-Cell Carcinoma.
- Published in:
- Oncology Practice Management, 2019, v. 9, n. 5, p. 1
- By:
- Publication type:
- Article
Applying Business Principles to Everyday Practice.
- Published in:
- Oncology Practice Management, 2019, v. 9, n. 5, p. 1
- By:
- Publication type:
- Article
Updated NCCN Breast Cancer Guideline Expands Treatment Recommendations for HR-Positive, HER2-Negative Disease.
- Published in:
- Oncology Practice Management, 2019, v. 9, n. 5, p. 13
- By:
- Publication type:
- Article
Current Strategies in the Management of CINV.
- Published in:
- Oncology Practice Management, 2019, v. 9, n. 5, p. 9
- By:
- Publication type:
- Article
Darolutamide, New Androgen Receptor Inhibitor, Extends Metastasis-Free Survival in High-Risk Prostate Cancer.
- Published in:
- Oncology Practice Management, 2019, v. 9, n. 5, p. 20
- By:
- Publication type:
- Article
Sacituzumab, a Novel Antibody-Drug Conjugate, Shows Activity in Heavily Pretreated Urothelial Cancer.
- Published in:
- Oncology Practice Management, 2019, v. 9, n. 5, p. 18
- By:
- Publication type:
- Article
Immunotherapy Strategies in the Updated NCCN Guideline for NSCLC Hinge on PD-L1 Testing.
- Published in:
- Oncology Practice Management, 2019, v. 9, n. 5, p. 16
- By:
- Publication type:
- Article